We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$371M
AUM Growth
-$19.1M
Cap. Flow
-$51.8M
Cap. Flow %
-13.97%
Top 10 Hldgs %
58.29%
Holding
41
New
8
Increased
14
Reduced
10
Closed
8

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$9.08M
2
RMD icon
ResMed
RMD
+$7.64M
3
STJ
St Jude Medical
STJ
+$6.14M
4
BIIB icon
Biogen
BIIB
+$5.17M
5
HNT
HEALTH NET INC
HNT
+$4.34M

Top Sells

Rank Stock Value
1
FRX
FOREST LABORATORIES INC
FRX
+$18.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$14.6M
3
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$12.9M
4
WCG
Wellcare Health Plans, Inc.
WCG
+$10.4M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$9.45M

Sector Composition

Rank Sector Weight
1 Healthcare 88.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
1
Eli Lilly
LLY
$1.05T
$41.1M 11.08%
804,947
+80,600
+11% +$4.04M
BSX icon
2
Boston Scientific
BSX
$65.4B
$31.2M 8.41%
2,594,800
+43,000
+2% +$508K
FRX
3
DELISTED
FOREST LABORATORIES INC
FRX
$26.4M 7.13%
440,349
-365,351
-45% -$18.4M
BAX icon
4
Baxter International
BAX
$11.7B
$24.2M 6.52%
639,932
+79,532
+14% +$2.88M
CAH icon
5
Cardinal Health
CAH
$53.5B
$19.8M 5.33%
295,700
-96,100
-25% -$5.87M
JNJ icon
6
Johnson & Johnson
JNJ
$609B
$18.9M 5.1%
206,550
-158,250
-43% -$14.6M
A icon
7
Agilent Technologies
A
$37.1B
$16.2M 4.37%
395,634
+7,689
+2% +$292K
EW icon
8
Edwards Lifesciences
EW
$49.4B
$14.3M 3.85%
1,302,000
+222,000
+21% +$2.5M
CBST
9
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$12.1M 3.27%
176,090
-27,952
-14% -$1.81M
TEVA icon
10
Teva Pharmaceuticals
TEVA
$37.3B
$11.9M 3.22%
297,700
+34,400
+13% +$1.35M
RVTY icon
11
Revvity
RVTY
$12.3B
$11.7M 3.15%
283,160
+19,460
+7% +$744K
LPNT
12
DELISTED
LifePoint Health, Inc.
LPNT
$11.4M 3.08%
216,000
+28,600
+15% +$1.44M
MDCO
13
DELISTED
Medicines Co
MDCO
$11.1M 3%
287,850
-30,500
-10% -$1.09M
UNH icon
14
UnitedHealth
UNH
$387B
$10.7M 2.88%
141,700
+56,700
+67% +$4.07M
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
$10.3M 2.78%
146,800
+24,300
+20% +$1.59M
THOR
16
DELISTED
THORATEC CORPORATION
THOR
$9.89M 2.67%
270,100
+40,100
+17% +$1.57M
AUXL
17
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
$9.59M 2.59%
462,504
-299,420
-39% -$5.64M
IRWD icon
18
Ironwood Pharmaceuticals
IRWD
$635M
$8.62M 2.32%
885,937
+380,886
+75% +$3.42M
DGX icon
19
Quest Diagnostics
DGX
$23.3B
$8.2M 2.21%
+153,128
New +$9.08M
BIO icon
20
Bio-Rad Laboratories Class A
BIO
$8.15B
$7.19M 1.94%
58,200
+4,400
+8% +$536K
RMD icon
21
ResMed
RMD
$28.9B
$7.11M 1.92%
+151,000
New +$7.64M
MASI
22
DELISTED
Masimo
MASI
$7.11M 1.92%
243,150
-132,541
-35% -$3.71M
STJ
23
DELISTED
St Jude Medical
STJ
$6.57M 1.77%
+106,000
New +$6.14M
BIIB icon
24
Biogen
BIIB
$30.4B
$5.59M 1.51%
+20,000
New +$5.17M
AGN
25
DELISTED
Allergan Inc
AGN
$5M 1.35%
45,000
-22,900
-34% -$2.19M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2013 Portfolio in Review

As of Q4 2013, Sector Gamma AS held 41 positions worth $371M, down 4.9% from $390M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Sector Gamma AS withdrew a net $51.8M in Q4 2013, closing 8 positions and reducing 10 holdings. Its most notable exit was ONYX PHARMACEUTICALS INC, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 77% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in Quest Diagnostics worth $8.2M.

  • Sector Gamma AS's largest Q4 2013 buy was Quest Diagnostics: 153,128 shares worth $8.2M.
  • Sector Gamma AS added most to UnitedHealth in Q4 2013, an estimated $4.07M increase.
  • Sector Gamma AS's biggest Q4 2013 reduction was FOREST LABORATORIES INC, cutting an estimated $18.4M.
  • Sector Gamma AS fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $12.9M.
  • Sector Gamma AS's ten largest holdings make up 58% of its $371M portfolio in Q4 2013.
  • Sector Gamma AS opened 8 new positions and closed 8 in Q4 2013.
  • Sector Gamma AS's portfolio value fell 4.9% quarter-over-quarter to $371M.

Based on Sector Gamma AS's 13F filing for Q4 2013, filed 14 Feb 2014.